Education
About Us
Working with TipRanks
Follow Us
Aytu BioScience (AYTU)
:AYTU
Total Valuation
Aytu BioScience has a market cap or net worth of $6.36M. The enterprise value is $11.17M.
Market Cap$6.36M
Enterprise Value$11.17M
Share Statistics
Aytu BioScience has 6,169,953 shares outstanding. The number of shares has decreased by -2.65% in one year.
Shares Outstanding6,169,953
Owned by Insiders8.41%
Owned by Institutions26.65%
Financial Efficiency
Aytu BioScience’s return on equity (ROE) is -0.57 and return on invested capital (ROIC) is -9.84%.
Return on Equity (ROE)-0.57
Return on Assets (ROA)-0.13
Return on Invested Capital (ROIC)-9.84%
Return on Capital Employed (ROCE)-0.09
Revenue Per Employee794.14K
Profits Per Employee-155.33K
Employee Count102
Asset Turnover0.69
Inventory Turnover2.09
Valuation Ratios
The current PE Ratio of Aytu BioScience is -1.00. Aytu BioScience’s PEG ratio is 0.02.
PE Ratio-1.00
PS Ratio0.11
PB Ratio0.57
Price to Fair Value0.57
Price to FCF-11.37
Price to Operating Cash Flow-11.37
PEG Ratio0.02
Income Statement
In the last 12 months, Aytu BioScience had revenue of 81.00M and earned -15.84M in profits. Earnings per share was -2.86.
Revenue81.00M
Gross Profit54.59M
Operating Income-5.25M
Pretax Income-14.08M
Net Income-15.84M
EBITDA-1.01M
Earnings Per Share (EPS)-2.86
Cash Flow
In the last 12 months, operating cash flow was 673.00K and capital expenditures -142.00K, giving a free cash flow of 531.00K billion.
Operating Cash Flow673.00K
Free Cash Flow531.00K
Free Cash Flow per Share0.09
Dividends & Yields
Aytu BioScience pays an annual dividend of ―, resulting in a dividend yield of ―
Dividend Per Share―
Dividend Yield―
Payout RatioN/A
Free Cash Flow Yield―
Earnings Yield―
Stock Price Statistics
Beta0.93
52-Week Price Change-61.40%
50-Day Moving Average1.21
200-Day Moving Average1.89
Relative Strength Index (RSI)40.82
Average Volume (3m)33.56K
Important Dates
Aytu BioScience upcoming earnings date is May 19, 2025, TBA Not Confirmed.
Last Earnings DateFeb 12, 2025
Next Earnings DateMay 19, 2025
Ex-Dividend Date―
Financial Position
Aytu BioScience as a current ratio of 0.99, with Debt / Equity ratio of 6.04%
Current Ratio0.99
Quick Ratio0.79
Debt to Market Cap0.96
Net Debt to EBITDA4.82
Interest Coverage Ratio-1.10
Taxes
In the past 12 months, Aytu BioScience has paid 1.77M in taxes.
Income Tax1.77M
Effective Tax Rate-0.13
Enterprise Valuation
Aytu BioScience EV to EBITDA ratio is -10.78, with an EV/FCF ratio of -7.86.
EV to Sales0.13
EV to EBITDA-10.78
EV to Free Cash Flow-7.86
EV to Operating Cash Flow-7.86
Balance Sheet
Aytu BioScience has $20.40M in cash and marketable securities with $0.00 in debt, giving a net cash position of -$18.54M billion.
Cash & Marketable Securities$20.40M
Total Debt$0.00
Net Cash-$18.54M
Net Cash Per Share-$3.01
Tangible Book Value Per Share-$4.47
Margins
Gross margin is 67.43%, with operating margin of -6.49%, and net profit margin of -19.56%.
Gross Margin67.43%
Operating Margin-6.49%
Pretax Margin-17.38%
Net Profit Margin-19.56%
EBITDA Margin-1.25%
EBIT Margin-11.46%
Analyst Forecast
The average price target for Aytu BioScience is $8.00, which is 11.43% higher than the current price. The consensus rating is Moderate Buy
Price Target$8.00
Price Target Upside676.70% Upside
Analyst ConsensusModerate Buy
Analyst Count1
Revenue Growth Forecast-30.19%
EPS Growth Forecast75.92%